Literature DB >> 32552382

Keeping standards of multiple sclerosis care through the COVID-19 pandemic.

Jaume Sastre-Garriga1, Mar Tintoré1, Xavier Montalban1.   

Abstract

Entities:  

Keywords:  COVID-19; Multiple sclerosis; disease-modifying therapies; epidemiology; service delivery

Mesh：

Substances：

Year:  2020        PMID： 32552382     DOI： 10.1177/1352458520931785

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  8 in total

1.  Multiple Sclerosis Patient Management During the COVID-19 Pandemic: Practical Recommendations From the Portuguese Multiple Sclerosis Study Group (GEEM).

Authors:  João J Cerqueira; Ana F Ladeira; Ana M Silva; Ângela Timóteo; José Vale; Lívia Sousa; Marta Arenga; Pedro Abreu; Rui Guerreiro; João de Sá
Journal:  Front Neurol       Date:  2021-03-08       Impact factor: 4.003

2.  Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre.

Authors:  Xavier Montalban; Jaume Sastre-Garriga; Alvaro Cobo-Calvo; Ana Zabalza; Jordi Río; Georgina Arrambide; Susana Otero-Romero; Paula Tagliani; Simón Cárdenas-Robledo; Mireia Castillo; Carmen Espejo; Marta Rodriguez; Pere Carbonell; Breogán Rodríguez; Luciana Midaglia; Ángela Vidal-Jordana; Carmen Tur; Ingrid Galan; Joaquín Castillo; Manuel Comabella; Carlos Nos; Cristina Auger; Mar Tintoré; Àlex Rovira
Journal:  J Neurol       Date:  2022-01-10       Impact factor: 6.682

3.  Research interrupted: The impact of the COVID-19 pandemic on multiple sclerosis research in the field of rehabilitation and quality of life.

Authors:  Rebecca Maguire; Sinead Hynes; Barbara Seebacher; Valerie J Block; Kathy M Zackowski; Johanna Jonsdottir; Marcia Finlayson; Prue Plummer; Jennifer Freeman; Barbara Giesser; Gloria von Geldern; Michelle Ploughman
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-08-26

4.  A National Representative, Cross-Sectional Study by the Hellenic Academy of NeuroImmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: Overall Impact and Willingness Toward Vaccination.

Authors:  Marina Boziki; Charis Styliadis; Christos Bakirtzis; Eleni Grigoriadou; Aggeliki-Styliani Sintila; Ioannis Nikolaidis; Aliki Vrienniou; Lotte Geys; Sygkliti-Henrietta Pelidou; Lesley Probert; Georgios Papazisis; Panagiotis Bamidis; Nikolaos Grigoriadis
Journal:  Front Neurol       Date:  2021-11-25       Impact factor: 4.003

5.  Multiple sclerosis management during the COVID-19 pandemic.

Authors:  Brandon P Moss; Kedar R Mahajan; Robert A Bermel; Kelsey Hellisz; Le H Hua; Timothy Hudec; Scott Husak; Marisa P McGinley; Daniel Ontaneda; Zhini Wang; Malory Weber; Paula Tagliani; Simón Cárdenas-Robledo; Ana Zabalza; Georgina Arrambide; Pere Carbonell-Mirabent; Marta Rodríguez-Barranco; Jaume Sastre-Garriga; Mar Tintore; Xavier Montalban; Morgan Douglas; Esther Ogbuokiri; Berna Aravidis; Jeffrey A Cohen; Ellen M Mowry; Kathryn C Fitzgerald
Journal:  Mult Scler       Date:  2020-08-10       Impact factor: 6.312

6.  Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey.

Authors:  Emilio Portaccio; Mattia Fonderico; Bernhard Hemmer; Tobias Derfuss; Bruno Stankoff; Krzysztof Selmaj; Mar Tintorè; Maria Pia Amato
Journal:  Mult Scler       Date:  2021-03-25       Impact factor: 6.312

Review 7.  The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic.

Authors:  Maryam Azimzadeh; Nora Möhn; Sajjad Ghane Ezabadi; Zahra Moghimi Esfandabadi; Alireza Soleimani; Elaheh Ranjbar; Maliheh Jahromi; Reihaneh Seyedebrahimi; Thomas Skripuletz; Farshad Moharrami Kasmaie
Journal:  Biomolecules       Date:  2021-09-17

8.  Innovating Care in Multiple Sclerosis: Feasibility of Synchronous Internet-Based Teleconsultation for Longitudinal Clinical Monitoring.

Authors:  Nima Sadeghi; Piet Eelen; Guy Nagels; Corinne Cuvelier; Katinka Van Gils; Marie B D'hooghe; Jeroen Van Schependom; Miguel D'haeseleer
Journal:  J Pers Med       Date:  2022-03-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.